Skip to content
★ Sign in to follow
RI

RecensMedical, Inc. Stock: price and insider trades · South Korea

리센스메디컬

KR·Mcap ₩52.5BHealth Care

No insider purchase over the last 90 days. The latest, by 김세왕, was filed 30 Jun 2026.

RecensMedical, Inc.: what insiders have been doing

RecensMedical, Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). 7 insiders have disclosed 11 filings since 9 November 2025.

The record shows 10 purchases on the open market, made by 7 insiders, against 1 sale by 1 insider. The totals exclude 11 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 board member and 1 chief executive.

With 11 filings in twelve months, the company is more active than the median of 7 filings across the 2,657 companies we follow on the same exchange. Our records for RecensMedical, Inc. go back to 2026, with 10 purchases and 1 sale on the open market in total.

The last purchase on record was published on 30 June 2026, which is 133 days ago. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
11
Thresholds
n/a
Buy Volume
€34M
10 ops. · all time
Sell Volume
€1M
1 ops. · all time

Who traded when

BuySale
김건호3 buys
한국산업은행2 buys1 sale
Bnk투자증권1 buy
Lb인베스트먼트1 buy
김세왕1 buy
스틱벤처스1 buy

+1 other insider

Since the insiders bought

  • Filed 07 Apr 2026 · 217 days ago · €7.0M
    -79.8%
    Entry ₩24,200 · Close 06 Nov 2026 ₩4,900
  • Filed 07 Apr 2026 · 217 days ago · €7.0M
    -79.8%
    Entry ₩24,200 · Close 06 Nov 2026 ₩4,900
  • Filed 07 Apr 2026 · 217 days ago · €6.9M
    -79.8%
    Entry ₩24,200 · Close 06 Nov 2026 ₩4,900

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩4,775
Analyst consensus
0.00/5
Income statement
Revenue₩8.8B
Gross profit₩4.3B49% margin
EBITDA-₩16.2B-184% margin
Net income-₩19.1B-169.4% margin
Valuation
PER (forward)8.7x
Balance sheet & cash
Market cap₩52.5B
Total debt₩804.7M
Free Cash Flow-₩9.4B
Debt / Equity30%
Profitability & ownership
% insiders30.5%
% institutions13.9%
Last declaration on 30 June 2026
Declarations14 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    상무이사Executives(filed)
    €97kest.0DART
    10,735 sharesShareKRXDART:20260630000401
    Canonical exit: 28 Sept 2026 (T+90)
  • ▼
    Related company / holdingExecutives(filed)
    €1.1Mest.0DART
    106,776 sharesKRXDART:20260609000509
  • ▲
    Executives
    0DART
    2,393,382 sharesKRXDART:20260522000099
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €7.0Mest.0DART
    578,116 sharesKRXDART:20260407002881
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Executives
    €7.0Mest.0DART
    581,355 sharesKRXDART:20260407002876
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €6.9Mest.0DART
    570,420 sharesKRXDART:20260407002017
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Executives
    €6.9Mest.0DART
    568,996 sharesKRXDART:20260407001554
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    공동 대표이사Executives
    0DART
    2,170,059 sharesShareKRXDART:20260407003522
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Executives
    0DART
    2,389,516 sharesKRXDART:20260407003492
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Executives
    0DART
    918,085 sharesKRXDART:20260406001188
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €6.0Mest.0DART
    570,420 sharesKRXDART:20260401004940
    Canonical exit: 29 Jun 2026 (T+90)

14 of 14 declarations

About RecensMedical, Inc.

리센스메디컬 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative medical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations